Search for Sandoz Inc and
  1. December 11, 2013

    J&J and Novartis mull appeal against €16m EU fines

    Johnson & Johnson and Novartis are considering whether to appeal against EU antitrust fines of €16m imposed this week for...

  2. August 8, 2013

    Surgery needed to keep Novartis in shape

    The strength of Novartis is that it does what a big drug company should do: it makes original drugs that cure or ease the...

  1. July 4, 2013

    China launches drug pricing probe

    China’s drug pricing authority has launched a wide-ranging probe into the costs of medicines at 60 domestic and...

  2. April 28, 2013

    Teva discovers sophisticated fakes of popular drug

    Leading generic drugmakers are stepping up quality inspections in Europe after unearthing a sophisticated counterfeiting...

  3. February 18, 2013

    Novartis: Vasella-tions

    Daniel Vasella has always put a high price on his worth, and so has the board of Novartis. As chairman and chief executive...

  4. May 3, 2012

    Sandoz gains dermatology lead with Fougera

    Novartis’s generic drugs division Sandoz has agreed to buy Fougera Pharmaceuticals for $1.53bn in cash in a deal that...

  5. April 24, 2012

    Novartis profits hit by US plant closure

    Novartis reported slipping sales and sharply lower net profits in the first quarter, as long-term pressures on health...

  6. January 25, 2012

    Novartis upbeat despite end of Diovan patent

    Novartis forecast it would maintain sales and suffer only potentially slightly lower operating profits this year, despite...

  7. November 11, 2011

    Art and design: What you can buy when you know the right people

    The jewellery and watch world has seen a series of art and design exhibitions lately. Some take a lateral approach, offering...

  8. September 9, 2011

    Movements: Emotions run high amid timepiece turmoil

    Seldom in the secretive world of Swiss watchmaking has a dispute become as public as the row that has erupted over movements...

  9. February 8, 2011

    Clariant poised for expansion

    Caught between volatile raw materials prices and spiralling competition, Europe’s speciality chemicals companies have...

  10. January 27, 2011

    Novartis confident despite market pressures

    Novartis remains optimistic about the current year, in spite of intensifying pricing pressure in many markets as stretched...

  11. October 21, 2010

    Novartis results lifted by new products

    Novartis demonstrated the benefits of continuing efficiency improvements and a strong pipeline of new drugs, as the Swiss...

  12. May 25, 2010

    GSK keeps up fight for control of drug

    When a feisty Indian generics company took on GlaxoSmithKline in its home market six years ago it won the first battle in a...

  13. May 24, 2010

    GSK keeps up fight for control of drug

    When a feisty Indian generics company took on GlaxoSmithKline in its home market six years ago it won the first battle in a...

  14. April 20, 2010

    Vectura hit by Sandoz move

    Vectura Group dropped 6.8 per cent to 41p after its development partner acquired a rival inhaler maker.Novartis's Sandoz...

  15. March 27, 2010

    Europe halts sale of Indian-sourced drug

    European regulators have halted sales of several variants of clopidogrel, a drug widely used to stop blood clots, in a move...

  16. January 27, 2010

    Novartis in stealthy pursuit of change

    Daniel Vasella may be among the more youthful chief executives in the international pharmaceutical industry - but he is also...

  17. January 26, 2010

    Novartis in stealthy pursuit of change

    Split decision: corporate governance lobbyists welcomed the resignation of Daniel Vasella (right). Joe Jimenez (left) will...

  18. October 8, 2009

    French generic drug raids point to wider probe

    The breadth of the European Commission’s antitrust probe into the generic industry launched this week suggests it extends...

  19. June 11, 2009

    Generic drugmakers adapt to survive

    The prospects seem bright right now for those making lower-cost generic drugs. Healthcare systems are increasingly looking...

  20. May 21, 2009

    Pfizer in tie-up with 2 Indian companies

    Pfizer, the world’s largest pharmaceuticals company, on Wednesday sharply accelerated its presence in generic drugs around...

  21. May 21, 2009

    Cancer drug push at Novartis

    Novartis yesterday said it would spend €925m ($1.3bn) to expand into speciality cancer drugs in an effort to strengthen its...

  22. May 20, 2009

    Cancer drug push at Novartis

    Novartis on Wednesday said it would spend €925m ($1.3bn) to expand into speciality cancer drugs in an effort to strengthen...

  23. May 4, 2009

    Vectura benefits from moving up ranks

    As the economy shrinks, and businesses fail, Britain’s traditionally risky biotech sector has been a surprising source of...

  24. March 10, 2009

    Hassan has seen string of deals

    Merck and its chief executive Richard Clark may be novices in large-scale mergers, but Fred Hassan, the head of...

  25. October 21, 2008

    Novartis paves way for chairman’s successor

    The board of Novartis on Monday slackened the strong grip Daniel Vasella, its veteran chairman and chief executive, holds...

  26. October 21, 2008

    New post at Novartis paves way for chairman's successor

    The board of Novartis yesterday slackened the strong grip Daniel Vasella, its veteran chairman and chief executive, holds...

  27. October 21, 2008

    New post at Novartis paves way for chairman's successor

    The board of Novartis yesterday slackened the strong grip Daniel Vasella, its veteran chairman and chief executive, holds...

  28. September 22, 2008

    Setback for Sandoz as WHO points to plant problems

    Sandoz, the generic drugs arm of Novartis of Switzerland, risks losing World Health Organisation authorisation to sell some...

  29. September 21, 2008

    WHO to warn customers over Sandoz drugs

    Sandoz, the generic drugs arm of Novartis of Switzerland, risks losing World Health Organisation authorisation to sell some...

  30. September 16, 2008

    BASF/Ciba

    Ciba is in a sandwich. The Swiss speciality chemicals producer is much smaller than both its raw materials suppliers and...

  31. September 15, 2008

    BASF/Ciba

    Ciba is in a sandwich. The Swiss speciality chemicals producer is much smaller than both its raw materials suppliers and its...

  32. September 8, 2008

    Swiss chemicals groups hit crossroads

    The Rhine flows broad and slow at Basel, the Swiss city whose fortunes were based in chemicals. But Ciba and Clariant, the...

  33. July 2, 2008

    AstraZeneca sees off generic rival

    Shares in AstraZeneca jumped 6 per cent in early London trading on Wednesday as a US court stopped a generic challenge to...

  34. June 23, 2008

    Africa beckons for serial entrepreneurs

    Dov and Anat Bar-Gera call themselves "serial entrepreneurs" - a term that might bring a smile to their teachers at Insead,...

  35. June 22, 2008

    From Insead to Africa

    Dov and Anat Bar-Gera call themselves “serial entrepreneurs” – a term that might bring a smile to their teachers at Insead,...

  36. April 30, 2008

    Swiss chemist who invented LSD dies

    Albert Hofmann, the Swiss scientist best known for synthesising the hallucinogenic drug LSD, has died aged 102. Hofmann...

  37. November 1, 2007

    Little room for scientists in pharma’s new generation

    Andrew Witty is in good company as he gears up to take charge of the world’s second largest pharmaceutical group next...

  38. September 10, 2007

    Similarity is breeding tougher competition

    As pharmaceutical companies struggle to respond to the intensifying threat to their medicines from generic rivals, one...

Search for Sandoz Inc and